A key component of the solution is to get more people living with hepatitis C virus (HCV) conclusively tested. The reason? An astonishing 75 percent of people living with HCV do not know they're infected, do not (yet) have outward symptoms of the disease, and therefore have not been linked to the care and treatment they may need to cure the virus and halt the progression of its life-threatening complications.
The CDC found these (and other) data compelling enough to issue screening guidelines on August 1, recommending that all U.S. baby boomers get a one-time test for HCV. The recommendation was a monumental leap forward, given that previous guidelines from the agency called for testing only individuals with certain risk factors for HCV infection.
Roughly four months later, however, the United States Preventive Services Task Force (USPSTF) - an independent group whose disease testing and vaccination recommendations carry heavy weight with health organizations and insurance companies - issued draft HCV testing guidelines that failed to pack the same punch as the CDC's unequivocal recommendation. Whereas the task force is currently prepared to recommend HCV testing for injection drug users and others at high risk, it says that there is only "small benefit" for testing all baby boomers and is therefore suggesting a "C" grade for a more universal testing recommendation.
A "C" grade isn't going to cut it, as it means many health care providers will fail to appreciate the gravity of the situation and the need for testing baby boomers--many of whom do not consider themselves at risk, either because of the stigma associated with hepatitis C or they've long forgotten risk factors from long ago--and, importantly, many public and private insurance programs may not cover necessary screening practices.
There's still time to make a difference. The USPSTF hepatitis C testing guidelines are still in draft form and a public comment period is open until 5:00 PM Eastern Time,